2Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Nigeria.
3Department of Radiotherapy, Lagos University Teaching Hospital, Idiaraba, Nigeria.
4Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Nigeria.
Background: Breast cancer is one of the most common malignant diseases in women and adjuvant combination chemotherapy has been shown to reduce mortality from this disease. Adherence to medical treatment is a multifaceted issue that can substantially alter the outcomes of therapy. Patient non-adherence to chemotherapy is the ultimate barrier to the treatment effectiveness. Objective: This study was carried out to determine the relationship between cancer chemotherapy adherence and breast cancer staging, patient’s perception of cancer care and patient’s socio-demographic characteristics. Material and method: This was a cross sectional study selection of respondents and was based on simple random sampling technique, 184 patients were interviewed and data was collected using a semi-structured questionnaire to obtain socio-demographic data, adherence data, and facility-related information. Results: There was a significant association between marital status and non-adherence (P = 0.013). Both separated and single subjects had higher proportion of non-adherence compared with married subjects. Analysis of perception of chemotherapy care revealed a significant association between the satisfaction score and non-adherence, with non-adherent patients showing higher scores or being less satisfied. The quality of service (P = 0.0052); rating of needs been met (P = 0.0079); rating on whether the services helped the subject (P = 0.0405); rating on the general satisfaction of the services provided (P = 0.0115); and rating on whether subject would seek help again (P = 0.0320) all had a significant association with non-adherence. Conclusion: The awareness of oncologist and patient of the problem of non-adherence and communication regarding the importance of adherence to therapy may improve health outcomes.
Cite this paper
|||Qiao, E.Q., Ji, M.H., Wu, J.Z., Li, J., Xu, X.Y., Ma, R., Zhang, Z.H., He, Y.J., Zha, Q.B., Song, X., Zhu, L.W. and Tang, J.-H. (2013) Joint Detection of Multiple Immunohistochemical Indices and Clinical Significance in Breast Cancer. Molecular and Clinical Oncology, 1, 703-710.|
|||Popoola, A.O., Ogunleye, O.O., Ibrahim, N.A., Omodele, F.O. and Igwilo, A.I. (2012) Five Year Survival of Patients with Breast Cancer at the Lagos State University Teaching Hospital, Nigeria. Online Journal of Medicine and Medical Science Research, 1, 24-31.|
|||Miller, E., Lee, H.J., Lulla, A., Hernandez, L., Gokare, P. and Lim, B. (2014) Current Treatment of Early Breast Cancer: Adjuvant and Neoadjuvant Therapy. Version 1, F1000 Research, 3, 198.|
|||Brezden, C.B., Phillips, K.-A., Abdolell, M., Buston, T. and Tannock, I.F. (2000) Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.|
|||Partridge, A.H., LaFountain, A., Mayer, E., Taylor, B.S., Winer, E. and Asnis-Alibozek, A. (2008) Adherence to Initial Adjuvant Anastrozole Therapy among Women with Early-Stage Breast Cancer. Journal of Clinical Oncology, 26, 556-562.|
|||Partridge, A.H., Archer, L., Kornblith, A.B., Gralow, J., Grenier, D., Perez, E., Wolff, A.C., Wang, X.F., Kastrissios, H., Berry, D., Hudis, C., Winer, E. and Muss, H. (2010) Adherence and Persistence with Oral Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104. Journal of Clinical Oncology, 28, 2418-2422.|
|||American College of Preventive Medicines (2011) Medication Adherence: Improving Health Outcomes.
|||Brown, M.T. and Bussell, J.K. (2011) Medication Adherence: WHO Cares? Mayo Clinical Proceedings, 86, 304-314.
|||Cramer, J.A., Roy, A., Burrell, A., Fairchild, C.J., Fuldeore, M.J., Ollendorf, D.A. and Wong, P.K. (2008) Medication Compliance and Persistence: Terminology and Definitions. Value in Health, 11, 44-47.|
|||Wyld, L. (2013) The Optimal Approach to Early Breast Cancer. EJC Supplements, 11, 1-2.
|||Osterberg, L. and Blaschke, T. (2005) Adherence to medication. The New England Journal of Medicine, 353, 487-497.
|||Fernandes, A.F., Cruz, A., Moreira, C., Santos, M.C. and Silva, T. (2014) Social Support Provided to Women Undergoing Breast Cancer Treatment: A Study Review. Advances in Breast Cancer Research, 3, 47-53.
|||Arora, N.K., Rutten, L.J.F., Gustafson, D.H., Moser, R. and Hawkins, R.P. (2007) Perceived Helpfulness and Impact of Social Support Provided by Family, Friends, and Health Care Providers to Women Newly Diagnosed with Breast Cancer. Psycho-Oncology, 16, 474-486.
|||Sheppard, V.B., Christopher, J. and Nwabukwu, I. (2010) Breaking the Silence Barrier: Opportunity to Address Cancer in African-Born Women. Journal of the National Medical Association, 102, 461-468.|
|||Anyanwu, S.N.C., Egwuonwu, O.A. and Ihekwoaba, E.C. (2011) Acceptance and Adherence to Treatment among Breast Cancer Patients in Eastern Nigeria. Breast, 20, S51-S53.
|||Adisa, A.O., Lawal, O.O. and Adesunkanmi, A.R.K. (2008) Evaluation of Patients’ Adherence to Chemotherapy for Breast Cancer. African Journal of Health Science, 15, 22-27.|
|||Reeler, A.V., Sikorayz, K. and Solomonx, B. (2008) Overcoming Challenges of Cancer Treatment Programmes in Developing Countries: A Sustainable Breast Cancer Initiative in Ethiopia. Clinical Oncology, 20, 191-198.|